ProterixBio, Inc. presenting at Biotech Showcase™ 2019
ProterixBio, Inc. will be attending Biotech Showcase™ 2019, to be held January 7-9th at the Hilton San Francisco Union Square. Biotech Showcase™, along with the Digital Medicine and Medtech Showcase, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and… Read more »
November is COPD Awareness Month
ProterixBio is transforming chronic disease management through novel bioclinical analytics and digital health technologies. Our first area of focus is COPD. Join us this November to spread awareness about this chronic disease. Imagine breathing through a straw – that’s what it feels like to live with COPD. Every four minutes, someone dies of chronic obstructive… Read more »
ProterixBio Presents Results from Multiple COPD Clinical Studies at the American Thoracic Society International Conference
Billerica MA, May 22, 2018 – ProterixBio, Inc. today announced that results from three clinical studies of subjects with chronic obstructive pulmonary disease (COPD) were presented at the American Thoracic Society International Conference this week. One presentation, “Prospective Evaluation of Algorithms Based on Blood Biomarkers as Guides for COPD Assessment and Risk Stratification,” highlighted that… Read more »